MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Tag: Alzheimer's disease

Alzheimer's disease

Latest news

Tag

Family Medicine & Nutrition

Lifetime Walking Intensity and Duration Reduce Amyloid-β Accumulation in Alzheimer’s Disease: Insights from a Korean Longitudinal Cohort

A 4-year longitudinal study reveals that long-duration, high-intensity lifetime walking is associated with reduced amyloid-β accumulation in older adults, suggesting a neuroprotective effect when initiated early in life.

Oct 20, 2025
Neurology

Moderate-to-Vigorous Physical Activity, p-tau181, and Cognition in Older Adults with Memory Complaints: Insights from the MAPT Study

Higher moderate-to-vigorous physical activity slows p-tau181 increase, a marker of Alzheimer’s pathology, but elevated p-tau181 diminishes exercise-related cognitive benefits in older adults.

Oct 20, 2025
Internal Medicine

Blood Biomarkers of Alzheimer’s Disease Predict Long-Term Muscle Strength Decline in Older Adults

This study links Alzheimer’s disease-related blood biomarkers with accelerated muscle strength loss over 12 years, highlighting the interplay between neurodegeneration and physical decline in aging populations.

Oct 20, 2025
Neurology

Advances in Alzheimer’s Diagnosis: A Comprehensive Review of CSF and Blood Biomarkers

This article reviews a systematic meta-analysis of 15 cerebrospinal fluid and blood biomarkers for Alzheimer’s disease, highlighting robust diagnostic performance of core markers T-tau, P-tau, and Aβ42 in clinical practice and researc

Oct 20, 2025Sign in to read
Nephrology

Assessing the Role of Kidney Function in Alzheimer’s Disease Blood Biomarker Interpretation and Amyloid-β Positivity Prediction

Kidney function influences certain Alzheimer’s disease blood biomarker levels but, within normal to mild impairment ranges, does not improve prediction of amyloid-β positivity, supporting the clinical utility of blood biomarkers in AD

Oct 20, 2025
Neurology

Brexpiprazole in Alzheimer’s Disease-Related Agitation: Modest Gains Amidst Safety Uncertainties

This review evaluates brexpiprazole’s efficacy and safety for agitation in Alzheimer’s disease, revealing modest symptom improvement but uncertain safety profiles, underscoring the need for individualized therapy and further res

Oct 12, 2025
Neurology

Alzheimer’s Disease: Navigating Controversies and Shaping Future Strategies

Recent advances in anti-β amyloid monoclonal antibodies offer promising reductions in Alzheimer’s disease progression but spark debate regarding their clinical impact, cost-effectiveness, and accessibility. Emerging biomarkers and preventiv

Oct 10, 2025
Clinical Updates

Clinically Meaningful Changes in Cognitive and Functional Measures Early in Alzheimer’s Disease: Insights from Population-Based Cohorts

This review synthesizes evidence on clinically meaningful within-patient changes in cognitive and functional assessments among individuals transitioning to mild cognitive impairment (MCI), highlighting implications for clinical trials and e

Sep 28, 2025Sign in to read
Clinical Updates

Promising Links Between Diabetes Medications and Alzheimer’s Disease Risk Reduction

Recent real-world data suggest GLP-1 receptor agonists and SGLT2 inhibitors may lower Alzheimer’s disease risk more effectively than DPP-4 inhibitors, highlighting the need for randomized trials to confirm potential neuroprotective benefits

Sep 25, 2025
Family Medicine & Nutrition

Anti-Inflammatory Diet and Alzheimer’s Disease Mortality: Insights from a National Cohort Study

Higher adherence to an anti-inflammatory diet is linked to lower all-cause mortality and a trend toward reduced Alzheimer’s disease mortality, particularly among men and non-Hispanic Whites, highlighting dietary modification as a pote

Sep 7, 2025Sign in to read
Clinical Updates

Genotype-Specific Metabolic Insights and Mediterranean Diet Impact on Dementia Risk and Cognitive Health

This article explores how genetic variants, plasma metabolites, and Mediterranean diet adherence interplay in modulating dementia risk and cognitive function, highlighting precision nutrition approaches for Alzheimer’s disease prevention.

Sep 4, 2025
Family Medicine & Nutrition

Precision Nutrition: Can the Mediterranean Diet Reduce Alzheimer’s Risk in APOE4 Carriers?

A large prospective study reveals that adherence to a Mediterranean diet significantly lowers dementia risk, especially in individuals carrying two copies of the APOE4 gene associated with Alzheimer’s disease, highlighting the potential of

Sep 4, 2025
Clinical Updates

Unraveling the Gut–Brain Connection: Tau Propagation via the Vagus Nerve in Alzheimer’s Disease

Recent research reveals that pathological tau can propagate from the brain to the colon through the vagal efferent pathway in Alzheimer’s disease, supporting a novel brain-to-gut axis involvement in disease progression and gut functio

Sep 4, 2025
Neurology

FDA Approves Subcutaneous Lecanemab for Maintenance Treatment in Early Alzheimer’s Disease: A Step Toward More Accessible Care

The FDA has approved a subcutaneous form of lecanemab for maintenance therapy in early Alzheimer’s, offering similar clinical benefits to IV dosing with improved convenience and safety, potentially transforming patient care delivery.

Sep 2, 2025
Clinical Updates

Therapeutic Potential of 40 Hz Light Stimulation in Alzheimer’s Disease: Mechanisms, Modalities, and Clinical Insights

This review synthesizes mechanistic, preclinical, and clinical evidence on 40 Hz light stimulation as a novel therapeutic approach to slow Alzheimer’s disease progression, highlighting safety, efficacy, and modality comparisons.

Aug 27, 2025
Clinical Updates

Obicetrapib Shows Promise in Slowing Alzheimer’s Disease Progression Through Lipid Modulation

Obicetrapib, a CETP inhibitor, significantly slowed Alzheimer’s disease biomarker progression over 12 months and improved p-tau217 levels in APOE4 carriers while also benefiting lipid profiles in cardiovascular disease patients.

Aug 17, 2025
Clinical Updates

Lithium Orotate as a Novel Therapeutic Avenue for Alzheimer’s Disease: Insights from the Latest Nature Study

A Nature study links lithium deficiency in the brain to Alzheimer’s onset and shows lithium orotate reverses memory loss in mice, offering new hope for Alzheimer’s therapy.

Aug 8, 2025Sign in to read
Clinical Updates

Advancing Alzheimer’s Risk Prediction: Multi-Ancestry Polygenic Risk Scores in Hispanic Populations

Multi-ancestry polygenic risk scores significantly improve Alzheimer’s disease risk prediction in Hispanic populations compared to traditional single-ancestry models and APOE genotyping alone.

Aug 7, 2025
Neurology

Understanding and Managing Alzheimer’s Disease: A Comprehensive Guide

An in-depth overview of Alzheimer’s disease, covering its causes, symptoms, diagnosis, treatment options, and caregiving strategies.

Aug 3, 2025
Clinical Updates

Elevated Risk of Alzheimer’s Disease and Related Dementias in Transfeminine Adults: Insights from a Large Cohort Study

Recent data reveal that transfeminine adults experience significantly higher prevalence of Alzheimer’s disease and related dementias compared to matched cisgender peers, independent of gender-affirming hormone therapy, highlighting ur

Aug 2, 2025
Prev
4 / 5
12345
Next

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story